Related Experiment Video
Updated: May 2, 2026

Detection of Protein Ubiquitination
Published on: August 19, 2009
NEDD4-1 is a proto-oncogenic ubiquitin ligase for PTEN
Xinjiang Wang1, Lloyd C Trotman, Theresa Koppie
1Cell Biology Program, Sloan-Kettering Institute, Memorial Sloan-Kettering Cancer Center, 1275 York Avenue, Box 522, New York, NY 10021, USA.
Abstract:
The tumor suppressor PTEN, a critical regulator for multiple cellular processes, is mutated or deleted frequently in various human cancers. Subtle reductions in PTEN expression levels have profound impacts on carcinogenesis. Here we show that PTEN level is regulated by ubiquitin-mediated proteasomal degradation, and purified its ubiquitin ligase as HECT-domain protein NEDD4-1. In cells NEDD4-1 negatively regulates PTEN stability by catalyzing PTEN polyubiquitination. Consistent with the tumor-suppressive role of PTEN, overexpression of NEDD4-1 potentiated cellular transformation. Strikingly, in a mouse cancer model and multiple human cancer samples where the genetic background of PTEN was normal but its protein levels were low, NEDD4-1 was highly expressed, suggesting that aberrant upregulation of NEDD4-1 can posttranslationally suppress PTEN in cancers. Elimination of NEDD4-1 expression inhibited xenotransplanted tumor growth in a PTEN-dependent manner. Therefore, NEDD4-1 is a potential proto-oncogene that negatively regulates PTEN via ubiquitination, a paradigm analogous to that of Mdm2 and p53.
Insights
The tumor suppressor PTEN
Area of Science:
- Oncology
- Molecular Biology
- Biochemistry
Background:
- The tumor suppressor PTEN is crucial for cellular processes and frequently altered in cancers.
- Reduced PTEN expression significantly impacts carcinogenesis.
- PTEN's role in cancer necessitates understanding its regulatory mechanisms.
Purpose of the Study:
- To elucidate the regulatory mechanism of PTEN protein levels.
- To identify the ubiquitin ligase responsible for PTEN degradation.
- To investigate the role of NEDD4-1 in PTEN regulation and cancer.
Main Methods:
- Ubiquitin-mediated proteasomal degradation assays.
- Purification and identification of PTEN's ubiquitin ligase.
- Cellular transformation assays.
- Analysis of NEDD4-1 expression in cancer models and human samples.
- Xenotransplanted tumor growth inhibition assays.
Main Results:
- PTEN levels are regulated by ubiquitin-mediated proteasomal degradation.
- NEDD4-1 was identified as the ubiquitin ligase for PTEN.
- NEDD4-1 catalyzes PTEN polyubiquitination, reducing PTEN stability.
- Overexpression of NEDD4-1 promoted cellular transformation.
- High NEDD4-1 expression correlated with low PTEN levels in PTEN-normal cancers.
- NEDD4-1 elimination inhibited tumor growth dependently on PTEN.
Conclusions:
- NEDD4-1 negatively regulates PTEN stability through ubiquitination.
- Aberrant NEDD4-1 upregulation can suppress PTEN in cancer.
- NEDD4-1 acts as a proto-oncogene by targeting PTEN.
- NEDD4-1 represents a potential therapeutic target in cancers with low PTEN.
More Related Videos
08:37Fluorescence-based Monitoring of PAD4 Activity via a Pro-fluorescence Substrate Analog
Published on: November 5, 2014
07:05Measuring Enzymatic Activity of Neurodevelopmental Disorder-Associated Deubiquitylating Enzymes via an In Vitro Ubiquitin Chain Cleavage Assay
Published on: September 27, 2024
Related Concept Videos
Covalently Linked Protein Regulators
These groups modify specific amino acids in a protein....
Nonsense-mediated mRNA Decay
Usually, Upf3 binds to an Exon Junction Complex (EJC) at mRNA splice sites. If a ribosome fully translates the mRNA,...
Canonical Wnt Signaling Pathway
Abnormal Proliferation
PI3K/mTOR/AKT Signaling Pathway
Catenins
Catenins in Cell Junctions
Catenins bind to cell adhesion molecules such as cadherins and link them to different cytoskeletal proteins depending on the type of cell junction. At the...